Ortin Global Ltd

Ortin Global Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Ortin Global Ltd

₹ 15.7 4.86%
02 Jun - close price
ortinlabsindia.com BSE: 539287 NSE: ORTINGLOBE
About

Incorporated in 1986, Ortin Laboratories Ltd manufactures pharmaceutical formulations.[1]

Key Points

Business Overview:[1]
OLL is engaged in the manufacturing and trading of pharmaceuticals, drugs, and Intermediates and is also engaged in real estate.

Website BSE NSE
  • Market Cap ₹ 13.3 Cr.
  • Current Price ₹ 15.7
  • High / Low ₹ 19.9 / 10.6
  • Stock P/E
  • Book Value ₹ 1.52
  • Dividend Yield 0.00 %
  • ROCE -32.1 %
  • ROE -46.0 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Debtor days have improved from 260 to 178 days.

Cons

  • Stock is trading at 10.3 times its book value
  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -45.0% over past five years.
  • Promoter holding is low: 1.23%
  • Company has a low return on equity of -72.7% over last 3 years.
  • Contingent liabilities of Rs.24.3 Cr.
  • Company might be capitalizing the interest cost
  • Company has high debtors of 178 days.
  • Promoter holding has decreased over last 3 years: -20.3%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
1.49 1.57 0.27 0.14 0.30 0.21 0.05 0.03 0.09 0.08 0.01 0.01 0.30
1.52 1.39 1.17 2.74 3.35 0.31 0.50 0.16 0.25 0.24 0.51 0.06 0.31
Operating Profit -0.03 0.18 -0.90 -2.60 -3.05 -0.10 -0.45 -0.13 -0.16 -0.16 -0.50 -0.05 -0.01
OPM % -2.01% 11.46% -333.33% -1,857.14% -1,016.67% -47.62% -900.00% -433.33% -177.78% -200.00% -5,000.00% -500.00% -3.33%
-0.03 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.00 0.00 0.00 0.00 0.00
Interest 0.12 0.11 0.15 0.14 0.08 0.00 0.02 -0.01 0.00 0.00 0.00 0.00 0.00
Depreciation 0.03 0.06 0.06 0.06 0.05 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Profit before tax -0.21 0.01 -1.11 -2.80 -3.18 -0.10 -0.47 -0.10 -0.16 -0.16 -0.50 -0.05 -0.01
Tax % -4.76% 0.00% 1.80% -0.71% 30.19% 0.00% 0.00% 10.00% 0.00% 6.25% 0.00% 0.00% 0.00%
-0.20 0.02 -1.12 -2.79 -4.14 -0.10 -0.47 -0.11 -0.16 -0.18 -0.50 -0.05 -0.01
EPS in Rs -0.25 0.02 -1.38 -3.43 -5.09 -0.12 -0.58 -0.14 -0.20 -0.22 -0.61 -0.06 -0.01
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
60.29 62.72 61.57 79.63 167.51 197.36 8.16 8.23 6.00 2.01 0.34 0.41
53.80 56.83 56.12 74.22 160.83 191.66 6.92 7.85 5.47 6.40 1.23 1.13
Operating Profit 6.49 5.89 5.45 5.41 6.68 5.70 1.24 0.38 0.53 -4.39 -0.89 -0.72
OPM % 10.76% 9.39% 8.85% 6.79% 3.99% 2.89% 15.20% 4.62% 8.83% -218.41% -261.76% -175.61%
0.00 0.57 0.32 0.45 0.13 0.18 0.05 0.19 0.01 -1.98 0.06 0.00
Interest 3.52 3.42 2.94 3.49 3.22 3.21 0.87 0.81 0.40 0.48 0.00 0.00
Depreciation 1.64 1.65 1.70 1.69 1.75 1.96 0.29 0.29 0.25 0.23 0.01 0.00
Profit before tax 1.33 1.39 1.13 0.68 1.84 0.71 0.13 -0.53 -0.11 -7.08 -0.84 -0.72
Tax % 32.33% 41.01% 55.75% 0.00% 30.43% 181.69% -623.08% -24.53% -18.18% 13.56% 1.19% 2.78%
0.90 0.83 0.50 0.68 1.28 -0.56 0.95 -0.40 -0.09 -8.04 -0.85 -0.74
EPS in Rs 0.53 0.49 0.30 0.40 0.76 -0.33 1.17 -0.49 -0.11 -9.89 -1.05 -0.91
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: -40%
5 Years: -45%
3 Years: -59%
TTM: 21%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 15%
Stock Price CAGR
10 Years: 0%
5 Years: -11%
3 Years: -7%
1 Year: 41%
Return on Equity
10 Years: -4%
5 Years: -25%
3 Years: -73%
Last Year: -46%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 16.94 16.94 16.94 16.94 16.94 16.94 8.13 8.13 8.13 8.13 8.13 8.13
Reserves 5.50 6.33 6.46 7.14 8.15 6.88 3.22 2.83 2.73 -5.31 -6.15 -6.89
20.96 20.85 17.34 17.34 19.47 19.57 6.94 6.14 6.45 1.80 0.25 1.01
23.87 21.22 20.79 32.24 60.53 73.13 2.97 3.61 3.89 2.05 1.55 2.40
Total Liabilities 67.27 65.34 61.53 73.66 105.09 116.52 21.26 20.71 21.20 6.67 3.78 4.65
21.83 21.63 20.69 20.03 21.29 22.45 14.38 14.21 13.96 0.01 0.00 0.01
CWIP 0.00 0.00 0.35 0.40 0.53 0.43 0.43 0.43 0.43 0.00 0.00 0.00
Investments 0.03 0.03 0.07 0.08 0.08 0.07 0.00 0.00 0.00 0.00 0.00 0.00
45.41 43.68 40.42 53.15 83.19 93.57 6.45 6.07 6.81 6.66 3.78 4.64
Total Assets 67.27 65.34 61.53 73.66 105.09 116.52 21.26 20.71 21.20 6.67 3.78 4.65

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
-1.38 0.52 1.94 1.56 6.52 3.30 18.03 2.15 -0.25 -4.79 -0.41
0.22 -0.86 -1.26 -0.90 -3.27 -3.09 0.07 -0.13 0.01 12.00 0.00
1.73 0.27 -0.82 0.07 -2.89 -1.33 -9.86 -0.48 0.90 -3.49 0.33
Net Cash Flow 0.58 -0.07 -0.14 0.73 0.37 -1.12 8.25 1.55 0.66 3.72 -0.09
Free Cash Flow -1.38 -0.92 0.83 0.77 3.38 0.28 18.03 2.02 -0.24 7.21 -0.41
CFO/OP -14% 17% 47% 40% 104% 72% 1,454% 566% -47% 80% 46%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 103.77 53.13 90.35 100.15 82.43 68.71 174.90 143.69 208.05 321.42 279.12 178.05
Inventory Days 192.30 148.72 158.21 152.21 100.07 117.80 169.10 136.29 279.94 4.92 34.76 0.00
Days Payable 151.09 24.82 108.10 143.09 145.12 155.80 123.82 61.88 166.89 7.87 69.52
Cash Conversion Cycle 144.97 177.04 140.45 109.28 37.38 30.70 220.17 218.10 321.10 318.47 244.36 178.05
Working Capital Days 29.00 16.24 37.29 41.48 16.82 11.24 -87.22 -109.10 -43.19 357.74 1,524.41 730.00
ROCE % 12.07% 10.92% 9.57% 9.44% 11.77% 8.94% 3.24% 1.58% 1.80% -40.58% -25.11% -32.14%

Insights

In beta
Mar 2015 Mar 2016 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Number of Employees
Nos.

Log in to view insights

Please log in to see hidden values.

Login
Actual Production - Capsules
Million Nos.
Actual Production - Injections (Vials/Ampoules/PFS)
Million Nos.
Actual Production - Liquids
KL
Actual Production - Tablets
Million Nos.
Installed Capacity - Capsules
Million Nos.
Installed Capacity - Injections (Vials/Ampoules/PFS)
Million Nos.
Installed Capacity - Liquids
KL
Installed Capacity - Tablets
Million Nos.

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
7.36% 7.37% 7.36% 1.23% 1.23% 1.23% 1.23% 1.23% 1.23% 1.23% 1.23% 1.23%
0.00% 0.00% 0.00% 0.00% 6.25% 6.25% 6.25% 6.53% 6.53% 1.68% 1.68% 1.68%
92.63% 92.64% 92.64% 98.76% 92.53% 92.52% 92.52% 92.24% 92.24% 97.08% 97.09% 97.10%
No. of Shareholders 12,18111,83612,31412,19211,95212,16512,09412,14412,03412,06011,83411,452

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports